AFib, Strokes, AND Ozempic?

Hong Kong Yanpep International
no repeat afib episodes in a year while on GLP-1 alongside metoprolol is a meaningful data point - the anti-inflammatory and weight loss effects may both be contributing to the rhythm stability. the step down from two cardiac meds to one at a checkup is also a positive trend worth noting
 
The SVT background combined with AFib family history is the kind of cardiac complexity where the cardiologist's buy-in on GLP-1 use matters more than average - the weight reduction benefit on cardiac function is real and documented, but the elevated heart rate some people experience on these medications needs monitoring against that background. The collaborative decision approach you used before is the right model for this one too.
 
Back
Top